Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients.
Saved in:
| Title: | Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients. |
|---|---|
| Authors: | Pluzanski A; Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland. Electronic address: adam.pluzanski@coi.pl., Krzakowski M; Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland., Kowalski D; Lung Cancer and Chest Tumours Department, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland., Dziadziuszko R; Department of Oncology and Radiotherapy, Gdanski Uniwersytet Medyczny, Gdansk, Poland. |
| Source: | ESMO open [ESMO Open] 2020 Nov; Vol. 5 (6), pp. e001011. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2059-7029 |
|---|---|
| DOI: | 10.1136/esmoopen-2020-001011 |
